Fig. 8From: LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axisRegulatory effects of NNT-AS1 silence on tumor growth and miR-186 or HMGB1 expression in vivo. a Tumor volume was assessed every 3 days following DDP-treatment. b Tumor weights were measured in different groups. c, d The expression of NNT-AS1, miR-186 and HMGB1 in lumps was measured by qRT-PCR or western blot, respectively. *P < 0.05Back to article page